T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSI
1751
DELISTED
Life Storage, Inc.
LSI
| $921K | ﹤0.01% |
14,700
| – | – |
|
1752
MGE Energy Inc
MGEE
$3.06B
| $920K | ﹤0.01% |
20,750
+1,000
| +5% | +$44.4K |
|
1753
Saic
SAIC
$5.35B
| $915K | ﹤0.01% |
17,828
+5,300
| +42% | +$277K |
|
|
CSR
1754
Centerspace
CSR
$939M
| $914K | ﹤0.01% |
12,186
+1,919
| +19% | +$151K |
|
|
PFC
1755
DELISTED
Premier Financial Corp. Common Stock
PFC
| $908K | ﹤0.01% |
55,344
+1,000
| +2% | +$16.2K |
|
|
MENT
1756
DELISTED
Mentor Graphics Corp
MENT
| $908K | ﹤0.01% |
37,780
+9,500
| +34% | +$222K |
|
1757
Morningstar
MORN
$7.76B
| $906K | ﹤0.01% |
12,100
-408,694
| -97% | -$29M |
|
1758
WisdomTree
WT
$3.44B
| $906K | ﹤0.01% |
42,200
+6,000
| +17% | +$112K |
|
1759
Mercury Insurance
MCY
$5.81B
| $895K | ﹤0.01% |
15,493
-1,800
| -10% | -$101K |
|
1760
Rithm Capital
RITM
$5.79B
| $891K | ﹤0.01% |
59,250
-4,700
| -7% | -$64.9K |
|
1761
Darling Ingredients
DAR
$10.4B
| $885K | ﹤0.01% |
63,200
+5,200
| +9% | +$85.5K |
|
1762
Timken Company
TKR
$9.1B
| $885K | ﹤0.01% |
21,000
| – | – |
|
|
RDC
1763
DELISTED
Rowan Companies Plc
RDC
| $882K | ﹤0.01% |
49,800
+3,800
| +8% | +$81.1K |
|
|
RPAI
1764
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $878K | ﹤0.01% |
54,800
+8,100
| +17% | +$136K |
|
1765
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $877K | ﹤0.01% |
51,360
| – | – |
|
|
AOL
1766
DELISTED
AOL INC COMMON STOCK
AOL
| $873K | ﹤0.01% |
22,040
| – | – |
|
|
PNNT
1767
Pennant Park Investment Corp
PNNT
$249M
| $868K | ﹤0.01% |
95,900
-1,265,300
| -93% | -$11.6M |
|
|
TGI
1768
DELISTED
Triumph Group
TGI
| $866K | ﹤0.01% |
14,500
+400
| +3% | +$24K |
|
1769
Emcor
EME
$36.7B
| $862K | ﹤0.01% |
18,560
-600
| -3% | -$26.1K |
|
|
HDS
1770
DELISTED
HD Supply Holdings, Inc.
HDS
| $851K | ﹤0.01% |
27,300
+11,548
| +73% | +$336K |
|
|
QLIK
1771
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $850K | ﹤0.01% |
27,300
+5,700
| +26% | +$174K |
|
|
VRNT
1772
DELISTED
Verint Systems
VRNT
| $848K | ﹤0.01% |
26,893
| – | – |
|
1773
Dycom Industries
DY
$12.3B
| $843K | ﹤0.01% |
17,263
| – | – |
|
1774
HEICO Corp
HEI
$51.9B
| $843K | ﹤0.01% |
33,691
+7,568
| +29% | +$187K |
|
1775
Associated Banc-Corp
ASB
$6.07B
| $842K | ﹤0.01% |
45,242
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.